These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22894630)

  • 1. Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management.
    de Souza F; Muxfeldt ES; Salles GF
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):735-45. PubMed ID: 22894630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. True resistant hypertension: is it possible to be recognized in the office?
    Muxfeldt ES; Bloch KV; Nogueira Ada R; Salles GF
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1534-40. PubMed ID: 16364821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension?
    Muxfeldt ES; Salles GF
    J Hypertens; 2008 May; 26(5):878-84. PubMed ID: 18398329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of the ambulatory arterial stiffness index in resistant hypertension.
    Muxfeldt ES; Cardoso CR; Dias VB; Nascimento AC; Salles GF
    J Hypertens; 2010 Jul; 28(7):1547-53. PubMed ID: 20467326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic influence of office and ambulatory blood pressures in resistant hypertension.
    Salles GF; Cardoso CR; Muxfeldt ES
    Arch Intern Med; 2008 Nov; 168(21):2340-6. PubMed ID: 19029499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant hypertension: a practical clinical approach.
    Muxfeldt ES; de Souza F; Salles GF
    J Hum Hypertens; 2013 Nov; 27(11):657-62. PubMed ID: 23636008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of nocturnal blood pressure reduction in resistant hypertension.
    Muxfeldt ES; Cardoso CR; Salles GF
    Arch Intern Med; 2009 May; 169(9):874-80. PubMed ID: 19433699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of baseline and serial changes in electrocardiographic strain pattern in resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    J Hypertens; 2010 Aug; 28(8):1715-23. PubMed ID: 20520577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [District program to improve the cardiovascular risk of resistant hypertensive patients in general medicine].
    Denolle T; Eon Y; Le Néel H; Seignard H; Battini J
    Arch Mal Coeur Vaiss; 2005; 98(7-8):761-6. PubMed ID: 16220744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characteristics of resistant hypertension in the Brazilian population.
    Faria AP; Sabbatini AR; Coca A; Moreno H
    Arq Bras Cardiol; 2013 Jun; 100(6):579-82. PubMed ID: 23657267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal nondipping and left ventricular hypertrophy in hypertension: an updated review.
    Cuspidi C; Giudici V; Negri F; Sala C
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):781-92. PubMed ID: 20528636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2012 Mar; 25(3):325-34. PubMed ID: 22158066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension.
    Fagard RH; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
    J Hum Hypertens; 2009 Oct; 23(10):645-53. PubMed ID: 19225527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure variability and cardiovascular risk in treated hypertensive patients.
    Pierdomenico SD; Lapenna D; Di Tommaso R; Di Carlo S; Esposito AL; Di Mascio R; Ballone E; Cuccurullo F; Mezzetti A
    Am J Hypertens; 2006 Oct; 19(10):991-7. PubMed ID: 17027816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining blood pressure goals: is it enough to manage total cardiovascular risk?
    Mancia G
    J Hypertens Suppl; 2009 Jul; 27(5):S3-8. PubMed ID: 19587552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.
    Clement DL; De Buyzere ML; De Bacquer DA; de Leeuw PW; Duprez DA; Fagard RH; Gheeraert PJ; Missault LH; Braun JJ; Six RO; Van Der Niepen P; O'Brien E;
    N Engl J Med; 2003 Jun; 348(24):2407-15. PubMed ID: 12802026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the effectiveness of hypertension management be improved?
    Ruilope LM
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):689-95. PubMed ID: 23750678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.